Enfermedad de Cushing

Carrera-Morodo, María; Larrañaga Cabrera, Andrea.
Med. clín (Ed. impr.) ; 158(8): 399-399, abril 2022. ilus
Artículo en Español | IBECS (España) | ID: ibc-204529

Documentos relacionados

  1. [Comparison of Different Doses of ACTH Used in ACTH Stimulation Test to Determine the Subtypes of Primary Aldosteronism].
  2. Crioplast<sup>®</sup> is a reliable device to ensure pre-analytical stability of adrenocorticotrophin (ACTH).
  3. Co-occurrence of Modifiable Risk Factors for Cardiovascular Disease amongst Diabetic Patients in Lagos State, Nigeria.
  4. [The Association Between Abdominal Obesity and Diabetes among Middle-aged and Older Adults with Normal BMI].
  5. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors.
  6. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
  7. CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.
  8. Plasma aldosterone response to ACTH stimulation test for diagnosis of primary aldosteronism: a cross-sectional study.
  9. Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
  10. Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testing.